Intralipid: Difference between revisions

No edit summary
Line 43: Line 43:
==See Also==
==See Also==
*[[Beta-blocker toxicity]]
*[[Beta-blocker toxicity]]
*[[Calcium channel blocker toxicity]]
*[[Local Anesthetic Systemic Toxicity (LAST)]]
*[[Local Anesthetic Systemic Toxicity (LAST)]]



Revision as of 03:56, 9 January 2016

General

  • Type: Lipid emulsion
  • Dosage Forms: 20% fat emulsion
  • Routes of Administration: IV
  • Common Trade Names: Intralipid

Adult Dosing

  • 1.5 ml/kg bolus[1]
    • Followed by 0.25 ml/kg/min for 20 min or until hemodynamic stability is achieved.[2]

Pediatric Dosing

Special Populations

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:


Comments

See Also

External Links

References

  1. Cave, G. Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review. 2009. 16(9)815–824
  2. Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.